1. Home
  2. Southern Africa
  3. South Africa

New trials to "nuke" HI virus

A South African medical school is set to begin HIV-AIDS treatment trials using electro-magnetic technology, the South African Press Association (SAPA) reported on Thursday.

Professors at the Nelson Mandela Medical School in the port city of Durban said respondents would be exposed to intense electro-magnetic emissions similar to those coming from microwaves and computers.

The university's head of medicine, Professor Umesh Lalloo said the trials are based on the probability that electro-magnetic frequency would causes a break in the viral genome.

"The patient would sit in a room for some time and absorb these emissions. Tests would then be done to determine the effect it had on the virus," Lalloo, said.

Hivex Limited, a local medical technology company said the treatment was created by Russian scientists and had never before been tested in a controlled scientific environment.

The clinical trials, which will begin next week, will involve 360 people living with HIV and span a period of six months.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join